ARTICLE | Clinical News
Amlexanox: Phase III
February 12, 2001 8:00 AM UTC
AKC said that in a 400-patient Phase III study in the U.S. and Europe, patients treated with its amlexanox formulation met the primary end point of complete healing of canker sores after 5 days compar...